Novozymes A/S is a Danish biotechnology company specializing in industrial enzymes and microbial solutions used across the chemical value chain. Headquartered in Bagsværd, Denmark, with a global R&D and manufacturing footprint including major fermentation facilities in Kalundborg, the company develops and produces biocatalysts and microbes at industrial scale.
Novozymes’ technologies are applied in household and industrial detergents, food and beverage processing, starch conversion and baking, textiles and leather, pulp and paper, bioenergy (including first- and second-generation ethanol), agriculture and animal nutrition, and environmental applications such as wastewater treatment. Its enzyme and microbial products enable catalysis under milder conditions, targeted substrate conversion, and by‑product valorization, supporting resource efficiency and lower energy use in chemical and process industries.
Established in 2000 through a demerger from Novo Nordisk, Novozymes has focused on fermentation-based manufacturing and application development in partnership with customers and research institutions. In 2024, Novozymes and Chr. Hansen combined to form Novonesis, integrating enzyme and microbial portfolios within a single biosolutions group.
